高级检索
    张小龙, 蒲强. 免疫联合化疗新辅助治疗早期非小细胞肺癌达到完全病理缓解的患者术后无需使用免疫辅助治疗[J]. 循证医学, 2024, 24(3): 142-144. DOI: 10.12019/j.issn.1671-5144.202403011
    引用本文: 张小龙, 蒲强. 免疫联合化疗新辅助治疗早期非小细胞肺癌达到完全病理缓解的患者术后无需使用免疫辅助治疗[J]. 循证医学, 2024, 24(3): 142-144. DOI: 10.12019/j.issn.1671-5144.202403011
    shu
    ZHANG Xiao-long, PU qiang. Adjuvant Immunotherapy Should not be Used for Early-Stage Non-Small Cell Lung Cancer Patients Achieving a Complete Pathological Response Post Neoadjuvant Chemo-Immunotherapy[J]. Journal of Evidence-Based Medicine, 2024, 24(3): 142-144. DOI: 10.12019/j.issn.1671-5144.202403011
    Citation: ZHANG Xiao-long, PU qiang. Adjuvant Immunotherapy Should not be Used for Early-Stage Non-Small Cell Lung Cancer Patients Achieving a Complete Pathological Response Post Neoadjuvant Chemo-Immunotherapy[J]. Journal of Evidence-Based Medicine, 2024, 24(3): 142-144. DOI: 10.12019/j.issn.1671-5144.202403011
    shu

    免疫联合化疗新辅助治疗早期非小细胞肺癌达到完全病理缓解的患者术后无需使用免疫辅助治疗

    Adjuvant Immunotherapy Should not be Used for Early-Stage Non-Small Cell Lung Cancer Patients Achieving a Complete Pathological Response Post Neoadjuvant Chemo-Immunotherapy

      摘要
      • HTML全文
      • 参考文献(9)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回